Resolution of oral hairy leukoplakia during therapy with 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) - PubMed (original) (raw)
Case Reports
Resolution of oral hairy leukoplakia during therapy with 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG)
C Newman et al. Ann Intern Med. 1987 Sep.
No abstract available
Similar articles
- 9-(1,3-Dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome.
Bach MC, Bagwell SP, Knapp NP, Davis KM, Hedstrom PS. Bach MC, et al. Ann Intern Med. 1985 Sep;103(3):381-2. doi: 10.7326/0003-4819-103-3-381. Ann Intern Med. 1985. PMID: 2992335 No abstract available. - Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine.
Rosecan LR, Stahl-Bayliss CM, Kalman CM, Laskin OL. Rosecan LR, et al. Am J Ophthalmol. 1986 Apr 15;101(4):405-18. doi: 10.1016/0002-9394(86)90638-0. Am J Ophthalmol. 1986. PMID: 3008560 - Clinical aspects of cytomegalovirus retinitis.
Palestine AG. Palestine AG. Rev Infect Dis. 1988 Jul-Aug;10 Suppl 3:S515-21. doi: 10.1093/clinids/10.supplement_3.s515. Rev Infect Dis. 1988. PMID: 2847288 Review. - Cotton-wool spots and cytomegalovirus retinitis in AIDS.
O'Donnell JJ, Jacobson MA. O'Donnell JJ, et al. Int Ophthalmol Clin. 1989 Summer;29(2):105-7. doi: 10.1097/00004397-198902920-00008. Int Ophthalmol Clin. 1989. PMID: 2541095 Review. No abstract available.
Cited by
- The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase.
Gustafson EA, Chillemi AC, Sage DR, Fingeroth JD. Gustafson EA, et al. Antimicrob Agents Chemother. 1998 Nov;42(11):2923-31. doi: 10.1128/AAC.42.11.2923. Antimicrob Agents Chemother. 1998. PMID: 9797227 Free PMC article. - Hairy leucoplakia.
Samaranayake LP, Pindborg JJ. Samaranayake LP, et al. BMJ. 1989 Feb 4;298(6669):270-1. doi: 10.1136/bmj.298.6669.270. BMJ. 1989. PMID: 2493891 Free PMC article. Review. No abstract available. - A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.
Perrine SP, Hermine O, Small T, Suarez F, O'Reilly R, Boulad F, Fingeroth J, Askin M, Levy A, Mentzer SJ, Di Nicola M, Gianni AM, Klein C, Horwitz S, Faller DV. Perrine SP, et al. Blood. 2007 Mar 15;109(6):2571-8. doi: 10.1182/blood-2006-01-024703. Epub 2006 Nov 21. Blood. 2007. PMID: 17119113 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical